FRIDAY, Apr 12 (HealthDay News) — Hot flashes and other upsetting side effects are a vital reason one-quarter of breast cancer patients do not start or do not finish their endorsed hormone-blocking therapy, a new investigate finds. Five years of daily pills — possibly tamoxifen or aromatase inhibitors — is endorsed for many women whose [...]
↧